Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome : Causes, Clinical Presentation, and Therapeutic Options
| dc.contributor.author | Bashir, Bilal | |
| dc.contributor.author | Ho, Jan H | |
| dc.contributor.author | Downie, Paul | |
| dc.contributor.author | Hamilton, Paul | |
| dc.contributor.author | Ferns, Gordon | |
| dc.contributor.author | Datta, Dev | |
| dc.contributor.author | Cegla, Jaimini | |
| dc.contributor.author | Wierzbicki, Anthony S | |
| dc.contributor.author | Dawson, Charlotte | |
| dc.contributor.author | Jenkinson, Fiona | |
| dc.contributor.author | Delaney, Hannah | |
| dc.contributor.author | Mansfield, Michael | |
| dc.contributor.author | Teoh, Yee | |
| dc.contributor.author | Miedzybrodzka, Zosia | |
| dc.contributor.author | Haso, Haya | |
| dc.contributor.author | Durrington, Paul N | |
| dc.contributor.author | Soran, Handrean | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.date.accessioned | 2023-06-19T16:32:01Z | |
| dc.date.available | 2023-06-19T16:32:01Z | |
| dc.date.issued | 2023-05 | |
| dc.description | Funding Information: We acknowledge support from the National Institute for Health Research (NIHR), Manchester Biomedical Research Centre, and the lipid disease fund. Figures were created with BioRender.com . | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 31 | |
| dc.format.extent | 3659380 | |
| dc.identifier | 254606585 | |
| dc.identifier | 66e9a052-06fe-4c9d-a995-0a238ea912c3 | |
| dc.identifier | 37233662 | |
| dc.identifier | 85160336714 | |
| dc.identifier.citation | Bashir, B, Ho, J H, Downie, P, Hamilton, P, Ferns, G, Datta, D, Cegla, J, Wierzbicki, A S, Dawson, C, Jenkinson, F, Delaney, H, Mansfield, M, Teoh, Y, Miedzybrodzka, Z, Haso, H, Durrington, P N & Soran, H 2023, 'Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome : Causes, Clinical Presentation, and Therapeutic Options', Metabolites, vol. 13, no. 5, 621. https://doi.org/10.3390/metabo13050621 | en |
| dc.identifier.doi | 10.3390/metabo13050621 | |
| dc.identifier.iss | 5 | en |
| dc.identifier.issn | 2218-1989 | |
| dc.identifier.other | PubMedCentral: PMC10224445 | |
| dc.identifier.other | unpaywall: 10.3390/metabo13050621 | |
| dc.identifier.other | ORCID: /0000-0003-2890-8136/work/175113394 | |
| dc.identifier.uri | https://hdl.handle.net/2164/20926 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85160336714&partnerID=8YFLogxK | en |
| dc.identifier.vol | 13 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Metabolites | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | atherosclerosis | en |
| dc.subject | chylomicronaemia syndrome | en |
| dc.subject | hypertriglyceridaemia | en |
| dc.subject | microvascular complications | en |
| dc.subject | pancreatitis | en |
| dc.subject | volanesorsen | en |
| dc.subject | QH426 Genetics | en |
| dc.subject | QD Chemistry | en |
| dc.subject | QR Microbiology | en |
| dc.subject | Molecular Biology | en |
| dc.subject | Biochemistry | en |
| dc.subject | Endocrinology, Diabetes and Metabolism | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject.lcc | QH426 | en |
| dc.subject.lcc | QD | en |
| dc.subject.lcc | QR | en |
| dc.title | Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome : Causes, Clinical Presentation, and Therapeutic Options | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Bashir_etal_M_Severe_Hypertriglyceridaemia_And_VOR.pdf
- Size:
- 3.49 MB
- Format:
- Adobe Portable Document Format
